Assessment of arterial ventricular coupling changes in patients under therapy with various antihypertensive agents by a non-invasive echocardiographic method

International Journal of Cardiology

Volumn 96, Issue 3, 2004, Pages 355-360

  Iakovou, Ioannis ^a,c   Karpanou, Evaggelia A ^a   Vyssoulis, Gregory P ^b   Toutouzas, Pavlos K ^b   Cokkinos, Dennis V ^a  

^a ONASSIS CARDIAC SURGERY CENTER   (Greece)

^b HIPPOKRATION HOSPITAL   (Greece)

^c Greece   (Greece)

Author keywords

Arterial ventricular coupling; Essential hypertension; Treatment

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ANGIOTENSIN 2 RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIHYDROPYRIDINE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT;

ADULT; AGED; ARTICLE; CALCULATION; CONTROLLED STUDY; CORRELATION ANALYSIS; DIASTOLIC BLOOD PRESSURE; DRUG EFFECT; ECHOCARDIOGRAPHY; ESSENTIAL HYPERTENSION; FEMALE; HEART EJECTION FRACTION; HEART HEMODYNAMICS; HEART LEFT VENTRICLE; HEART STROKE VOLUME; HEART VENTRICLE FUNCTION; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PULSE PRESSURE; SYSTOLIC BLOOD PRESSURE; TREATMENT OUTCOME;

ADULT; AGED; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; CORONARY VESSELS; ELASTICITY; FOLLOW-UP STUDIES; HEART VENTRICLES; HUMANS; HYPERTENSION; MIDDLE AGED; STROKE VOLUME;

EID: 4143120134     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2003.07.022     Document Type: Article

References (36)

1. Dunlap S.H., Sueta C.A., Tomasko L., Adams K.F. Jr. Association of body mass, gender and race with heart failure primarily due to hypertension. J. Am. Coll. Cardiol. 24:1999;1602-1608
2. Hall W.D. Risk reduction associated with lowering systolic blood pressure: review of clinical trial data. Am. Heart J. 138:1999;225-230
3. Wilson P.W. From hypertension to heart failure: what have we learned? Clin. Cardiol. (Suppl. 5):1999;V1-V10
4. Asanoi H., Sasayama S., Kameyama T. Ventriculoarterial coupling in normal and failing heart in humans. Circ. Res. 65:1989;483-493
5. Kelly R.P., Ting C., Tsong-Ming Y., et al. Effective arterial elastance as index of arterial vascular load in humans. Circulation. 86:1992;513-521
6. Kameyama T., Asanoi H., Ishizaka S., Sasayama S. Ventricular load optimization by unloading therapy in patients with heart failure. J. Am. Coll. Cardiol. 17:1991;199-207
7. Cohen-Solal A., Dahan M., Guiomard A., et al. Effets du vieillissement sur le couplage "foncionnel" ventricule gauche-système artériel chez l'homme. Arch. Mal. Coieur. 86:1993;1095-1097
8. Mérillon J.P., Masquet C., Dahan M., et al. Changes in left ventricular performance during chronic pressure or volume overload: importance of physical properties of the arterial system. J. Cardiovasc. Pharmacol. 7:1985;S36-S40
9. Himelman R.B., Cassidy M.M., Laudzberg J.S., Schiller N.B. Reproducibility of quantitative two-dimensional echocardiography. Am. Heart J. 115:1988;425
10. Vyssoulis G.P., Karpanou E.A., Pitsavos E.C., et al. Regression of left ventricular hypertrophy in systemic hypertension with beta blockers. Am. J. Cardiol. 70:1992;1209-1211
11. McKelvie R., McConachie D., Yusuf S. Role of angiotensin converting enzyme inhibitors in patients with left ventricular dysfunction and congestive heart failure. Eur. Heart J. 15:1994;9-13
12. Regitz-Zagrosek V., Neuss M., Fleck E. Effects of angiotensin receptor antagonists in heart failure: clinical and experimental aspects. Eur. Heart J. 16:1995;86-91
13. Katz S.D., Radin M., Graves T., et al. Effect of aspirin and ifetroban on skeletal muscle blood flow in patients with congestive heart failure treated with enalapril. J. Am. Coll. Cardiol. 34:1999;170-176
14. Conway J., Lawrens P. Hemodynamic and hypotensive effects of long-term therapy with chlorothiazide. Circulation. 21:1960;21-26
15. Abrahams Z., Tan L.L.Y., Pang M.Y.M., et al. Demonstration of an in vitro direct vascular relaxant effect of diuretics in the presence of plasma. J. Hypertens. 14:1996;381-388
16. Shah S., Khatri I., Freis E.D. Mechanism of antihypertensive effect of thiazide diuretics. Am. Heart J. 95:1998;611-618
17. Tomada F., Takata M., Hirai A., et al. Hemodynamic and endocrinological effects of a new selective a1-blocking agent, terazosin, in patients with essential hypertension: results of long-term treatment. J. Am. Coll. Cardiol. 7:(Suppl. A):1996;26
18. Van den Meiracker A.H., Man in't Veld A.J., Boomsma F., et al. Hemodynamic and β-adrenergic receptor adaptations during long-term β-adrenoceptor blockade. Studies with acebutolol, atenolol, pindolol, and propranolol in hypertensive patients. Circulation. 80:1989;903-914
19. Van den Meiracker A.H., Man in't Veld A.J., Ritsema van Eck H.J., et al. Systemic and renal vasodilation after beta-adrenoceptor blockade with pindolol: a hemodynamic study on the onset and maintenance of its antihypertensive effect. Am. Heart J. 112:1986;368-374
20. Cholley B., Shoroff S., Sandelski J., et al. Differential effects of chronic oral antihypertensive therapies on systemic arterial circulation and ventricular energetics in African-American patients. Circulation. 91:1995;1052-1062
21. Godfraind T., Salomone S., Dessy C., et al. Selectivity scale of calcium antagonists in the human cardiovascular system based on in vitro studies. J. Cardiovasc. Pharmacol. 20:1992;S34-S41
22. Ferrari R., Cucchini F., Bolognesi R., et al. How do calcium antagonists differ in clinical practice. Cardiovasc. Drugs Ther. 8:1994;565-575
23. Bolognesi R., Cucchini F., Manca C., Ferrari R. Effects of verapamil and nifedipine on rate of left ventricular relaxation in coronary arterial disease patients. Int. J. Cardiol. 14:1987;333-341
24. Chen C.H., Nakayama M., Nero E., et al. Coupled systolic-ventricular and vascular stiffening with age. Implications for pressure regulation and cardiac reserve in the elderly. J. Am. Coll. Cardiol. 32:1998;1221-1227
25. Opie L.H. Pharmacological differences between calcium antagonists. Eur. Heart J. 18:(Suppl. A):1997;A71-A79
26. Haber H.L., Siemek C.L., Bergin J.D., et al. Bolus intravenous nitroglycerin predominantly reduces afterload in patients with excessive arterial elastance. J. Am. Coll. Cardiol. 22:1993;251-257
27. Takaoka H., Takeuchi M., Odake M., et al. Comparison of the effects on arterial-ventricular coupling between phosphodiesterase inhibitor and dobutamine in the diseased human heart. J. Am. Coll. Cardiol. 22:1993;598-606
28. Rinder M., Miller T., Afhsani A., et al. Effects of endurance exercise training on left ventricular systolic performance and ventriculoarterial coupling in patients with coronary artery disease. Am. Heart J. 138:1999;161-174
29. Nitenberg A., Antony I., Loiseau A. Ventriculoarterial coupling and left ventricular performance in hypertensive patients with left ventricular hypertrophy. Arch. Mal. Coeur Vaiss. 90:1997;1025-1030
30. Nitenberg A., Loiseau A., Antony I. Left ventricular efficiency in hypertensive patients with and without increased myocardial mass and with normal pump function. Am. J. Hypertens. 14:2001;1231-1238
31. Burkhoff D., Sagawa K. Ventricular efficiency predicted by an analytical model. Am. J. Physiol. 250:1986;H1021-H1027
32. Senzaki A., Chen-Huan C., Kass D. Single-beat estimation of end systolic pressure-volume relation in humans. A new method with the potential for noninvasive application. Circulation. 94:1996;2497-2506
33. Kass D.A. Age-related changes in ventricular-arterial coupling: pathophysiologic implications. Heart Fail. Rev. 7:2002;51-62
34. Madhavan S., Ooi W., Cohen H., et al. Relation of pulse pressure and blood pressure reduction to the incidence of myocardial infarction. Hypertension. 23:1994;394-401
35. Williams J.C., Fotherby M.D., Foster L.A., et al. Mononuclear cell adhesion to collagen ex vivo is related to pulse pressure in elderly patients. Atherosclerosis. 151:2000;463-469
36. Lehmann E., Hopkins K., Rawesh A., et al. Relation between number of cardiovascular risk factors/events and noninvasive doppler ultrasound assessments of aortic compliance. Hypertension. 32:1998;565-569